ARAI Arrive AI Inc.
$0.23▼ -2.49%
Technology
Other
Volume 104.7K
Avg Volume (10D) 285.9K
Key Metrics & Fundamentals
Market Cap
$12.00M
P/E Ratio
–
Div Yield
–%
52W Range
0.22 - 6.86
% vs 50 MA
-15.99%
% vs 200 MA
-80.25%
RSI-14
43.7
MACD Histogram
+0.0000
Beta (1Y vs SPY)
3.55
Free Cash Flow
-$3.55M
Gross Rev
$14,700
Gross Profit
$14,700
EBITDA
-$4.31M
COGS
–
Operating Exp
$4.37M
Operating Income
-$4.36M
EBIT
-$4.36M
Pretax Income
-$14.08M
Net Income
-$14.08M
EPS (Diluted)
-0.28
Price & Volume History
Loading chart…
Recent News
Arrive AI to Present at the 28th Annual H.C. Wainwright Global Investment Conference in New York
ACCESS Newswire · Sep 3, 2026 8:02 PM
Arrive AI Resolves Streeterville Repayment Trigger, Strengthening Financial Flexibility and Focus on Execution
ACCESS Newswire · Aug 19, 2026 1:32 PM
Arrive AI Streamlines Workforce, Citing AI, Team Leverage and Ahead-of-Schedule Evolution of its Operating Model
ACCESS Newswire · Aug 19, 2026 1:32 PM
Arrive AI Targets Healthcare Logistics Opportunity as Autonomous Delivery Moves Closer to the Pharmacy
InvestorsHub · Aug 14, 2026 12:00 PM
Arrive AI (ARAI) Q2 2026 Earnings Call Transcript
Motley Fool · Aug 14, 2026 2:43 AM
Arrive AI Inc. Q2 2026 Earnings Call Summary
Moby · Aug 14, 2026 12:32 AM
Arrive AI Inc (ARAI) (Q2 2026) Earnings Call Highlights: Strategic Expansion and Financial ...
GuruFocus.com · Aug 13, 2026 11:06 PM
Arrive AI Reports Second Quarter 2026 Results and Highlights Growing Commercial Pipeline
ACCESS Newswire · Aug 13, 2026 12:00 PM
Arrive AI Inc (ARAI) Q2 2026 Earnings Report Preview: What To Look For
GuruFocus.com · Aug 12, 2026 1:35 PM
Arrive AI Targets the Future of Pharmacy Delivery with LifeSpan Pharmacy Collaboration
InvestorsHub · Aug 4, 2026 4:19 PM
Financial Overview - Income Statement
Quarterly
Jun 2026
See ARAI's money flow as a full page
Social Sentiment
Avg +0.80 · 1 posts
AI Analysis
Click Generate Analysis for an AI-powered summary, bull & bear case, and recent performance review.
Not financial advice.
All data, scores, charts, and analysis on this site are provided for informational and educational
purposes only and do not constitute financial, investment, legal, or tax advice.
Past performance is not indicative of future results.
See our Legal Notice for full details.